![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Hemosense | AMEX:HEM | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
RNS Number:9734L Hemscott PLC 05 June 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Hemscott plc 2. Name of shareholder having a major interest Dairy Brands New Zealand Limited 3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 - 4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them - 5. Number of shares / amount of stock acquired 16,071,224 6. Percentage of issued class 50.01% 7. Number of shares / amount of stock disposed - 8. Percentage of issued class - 9. Class of security Ordinary shares 10. Date of transaction 30 May 2003 11. Date company informed 5 June 2003 12. Total holding following this notification 16,071,424 13. Total percentage holding of issued class following this notification 50.01% 14. Any additional information Dairy Brands New Zealand Limited and persons acting in concert with it now hold 17,701,277 ordinary shares in Hemscott, representing 55.08 per cent. of the issued share capital of Hemscott. 15. Name of contact and telephone number for queries Natalie Newton, Chief Financial Officer 16. Name and signature of authorised company official responsible for making this notification Natalie Newton Date of notification 5 June 2003 The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material. This information is provided by RNS The company news service from the London Stock Exchange END HOLSSAFLISDSELM
1 Year Hemosense Chart |
1 Month Hemosense Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions